Skip to main content

Advertisement

SpringerLink
Log in

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008

  • Meeting Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

AC:

Adherent cells

APC:

Antigen-presenting cells

BMP:

Bone morphogenetic proteins

CAR:

Chimeric antigen receptors

CRC:

Colorectal cancer

CSC:

Cancer stem cells

CTA:

Cancer testis antigens

CTL:

Cytotoxic T lymphocyte

CTLA-4:

Cytotoxic T lymphocyte antigen-4

DC:

Dendritic cells

DTIC:

Dacarbazine

GBM:

Glioblastoma multiforme

HDI:

High-dose interferon

IL:

Interleukin

i.v.:

Intravenous

LV:

Lentiviral vectors

mAb:

Monoclonal antibody

mRNA:

messenger RNA

MSC:

Melanoma stem cells

NS:

Neurospheres

NSCL:

Non small cell lung

NK:

Natural killer

PBMC:

Peripheral blood mononuclear cells

RAGE:

Advanced glycation end products

TAA:

Tumor-associated antigens

TCR:

T cell receptor

Treg:

T regulatory cells

Acknowledgments

This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro (H.J.M.N. fellow) and by Alleanza Contro il Cancro (Progetto Rete Nazionale per Studi Clinici e di Strutture GMP per le Bioterapie dei Tumori).

Author information

Authors and Affiliations

  1. Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Strada delle Scotte 14, 53100, Siena, Italy

    Michele Maio, Hugues J. M. Nicolay & Ester Fonsatti

  2. Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy

    Michele Maio & Hugues J. M. Nicolay

  3. Unit of Medical Oncology and Innovative Therapy, Melanoma Cooperative Group, Istituto Nazionale Tumori “Fondazione Pascale” Naples, Naples, Italy

    Paolo A. Ascierto

  4. Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy

    Filippo Belardelli

  5. Clinical Research Unit III, Sigma Tau SpA, Rome, Italy

    Roberto Camerini

  6. Immunotherapy and Gene Therapy Unit, Department of Experimental Oncology, Fondazione Istituto Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan, Italy

    Mario P. Colombo

  7. Division of Medical Oncology A, National Institute for Cancer Research, Genoa, Italy

    Paola Queirolo

  8. Immunotherapy and Somatic Cell Therapy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Forlì, Italy

    Ruggero Ridolfi

  9. Division of Molecular Oncology, San. Raffaele Scientific and University Institute, Milan, Italy

    Vincenzo Russo & Giorgio Parmiani

Authors
  1. Michele Maio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hugues J. M. Nicolay
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo A. Ascierto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Filippo Belardelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Roberto Camerini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mario P. Colombo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paola Queirolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ruggero Ridolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vincenzo Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ester Fonsatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Giorgio Parmiani
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the NIBIT

Corresponding author

Correspondence to Michele Maio.

Appendix: NIBIT co-authors

Appendix: NIBIT co-authors

  • Paola Aimone, Glaxo Smith-Kline, Italy

  • Alessandro Cignetti, Institute for Cancer Research and Treatment, Candiolo, Italy

  • Giulia Casorati, San Raffaele Scientific Institute, Milan, Italy

  • Chiara Castelli, Istituto Nazionale Tumori, Milan, Italy

  • Michele Del Vecchio, Istituto Nazionale Tumori, Milan, Italy

  • Anna Maria Di Giacomo, Azienda Ospedaliera Universitaria Senese, Siena, Italy

  • Massimo Di Nicola, Istituto Nazionale Tumori, Milan, Italy

  • Franco Fais, University of Genoa, Italy

  • Silvano Ferrini, National Institute for Cancer Research, Genoa, Italy

  • Raffaella Fontana, San Raffaele Scientific Institute, Milan, Italy

  • Flora Iovino, University of Palermo, Italy

  • Thomas Lander, CureVac GmbH, Tuebingen, Germany

  • Pier Luigi Lollini, University of Bologna

  • Cristina Maccalli, Istituto Nazionale Tumori, Milan, Italy

  • Angelo Manfredi, San Raffaele Scientific Institute, Milan, Italy

  • Paolo Neyroz, University of Bologna, Italy

  • Paola Nisticò, Regina Elena Cancer Institute, Rome, Italy

  • Serena Pellegatta, Istituto Neurologico C. Besta and IFOM-IEO Campus, Milan, Italy

  • Enrico Proietti, Istituto Superiore Sanità, Rome, Italy

  • Licia Rivoltini, Istituto Nazionale Tumori, Milan, Italy

  • Antonio Rosato, Istituto Oncologico Veneto, Padua, Italy

  • Angela Santoni, University La Sapienza of Rome, Italy

  • Luca Sigalotti, Centro di Riferimento Oncologico, IRCCS, Aviano, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maio, M., Nicolay, H.J.M., Ascierto, P.A. et al. Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008. Cancer Immunol Immunother 59, 963–969 (2010). https://doi.org/10.1007/s00262-009-0696-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-009-0696-5

Keywords

Search

Navigation